Board of Directors
Tamara A. Seymour has served as a member of Beacon’s Board and Chair of the Audit Committee of the Board since September 2018. Tamara currently provides management and financial consulting services for companies in the life science industry. Previously she served as Chief Financial Officer of Signal Genetics, Inc., a publicly-traded molecular diagnostics company, from 2014 to 2017. She served as Chief Financial Officer of HemaQuest Pharmaceuticals, Inc., a venture-backed clinical-stage drug development company, from 2010 to 2014. From 2001 to 2009, she served as Chief Financial Officer for Favrille, Inc., a publicly-traded clinical-stage drug development company. While at these companies, she was instrumental in raising over $250 million in multiple private and public equity and debt financings, including Favrille's IPO. In addition, she was instrumental in M&A transactions and led the investor relations activities for each of the companies. From 1991 to 2001, Tamara consulted as chief financial officer for a number of biotechnology companies. From 1988 through 1991, she was Director of Finance and Controller with Agouron Pharmaceuticals, Inc. From 1980 and 1988, she worked with Deloitte & Touche LLP and PricewaterhouseCoopers LLP in various positions including audit manager from 1985 to 1988. Tamara is a Certified Public Accountant. She received an MBA with an emphasis in Finance from Georgia State University and a bachelor's degree in Business Administration with an emphasis in Accounting from Valdosta State University.